Project description
Dietary antioxidants to reduce oxidative stress
Oxidative stress occurs when the human ability to counteract the harmful effects of reactive oxygen via antioxidants is decreased. It is implicated in many diseases including cancer, diabetes, rheumatoid arthritis, cardiovascular disease, and stroke. Astaxanthin is the most effective natural antioxidant found in some algae and in the yeast strain Phaffia. Its market uptake is poor due to low concentration limiting its efficacy coupled with an unpleasant flavour and odour. AstaFerm™ is a proprietary process for producing high-quality concentrated astaxanthin crystals with low odour and neutral flavour from the fermented biomass of yeasts. With EU funding, AstaFerm project members will optimise the extraction process and scale it up for clinical studies along with a commercialisation strategy and supply chain set-up.
Objective
Oxidative stress is an imbalance between the production of reactive oxygen species and the ability of the human body to counteract their harmful effects through neutralization by antioxidants. Oxidative stress is the major cause of the cellular damage at the basis of age-related diseases, such as atherosclerosis, cancer, diabetes, rheumatoid arthritis, cardiovascular diseases, chronic inflammations, stroke and other degenerative diseases. The best way to reduce oxidative stress is the intake of antioxidants. Astaxanthin (AST) is the most effective natural antioxidant used to quench oxidative stress. However, the efficacy of AST currently available on the market is very low, due to its poor concentration, and only suitable for a limited number of applications due to its unpleasant flavour and odour.
NextFerm offers AstaFerm™, the most effective anti-oxidant dietary supplement made of natural Astaxanthin. AstaFerm™ is an ingredient for dietary supplement composed of an Astaxanthin-rich extract derived from the fermented biomass of yeast strain. AstaFerm™ proprietary process represents the most efficient, innovatory, and sustainable way to produce a natural, high quality and bio-available form of Astaxanthin, with a neutral flavour and odour. The results are highly concentrated AST crystals that can be refined in multiple applications which today are not available on the market.
During the phase 1 project, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Within the overall innovation project NextFerm will optimise the extraction process of AstaFerm™ before scaling up and perform clinical studies.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine rheumatology
- medical and health sciences clinical medicine cardiology cardiovascular diseases arteriosclerosis
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
2069208 YOKNEAM ILIT
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.